HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

D J Smith Selected Research

Glucosyltransferases

2/2007Immunogenic and protective potential of mutans streptococcal glucosyltransferase peptide constructs selected by major histocompatibility complex class II allele binding.
8/2003Remote glucosyltransferase-microparticle vaccine delivery induces protective immunity in the oral cavity.
7/2001Diepitopic construct of functionally and epitopically complementary peptides enhances immunogenicity, reactivity with glucosyltransferase, and protection from dental caries.
5/2000Coimmunization with complementary glucosyltransferase peptides results in enhanced immunogenicity and protection against dental caries.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


D J Smith Research Topics

Disease

9Dental Caries (Decay, Dental)
12/2008 - 05/2000
7Infections
08/2008 - 05/2000
3Body Weight (Weight, Body)
08/2007 - 09/2005
3Thinness
03/2003 - 05/2002
2Wounds and Injuries (Trauma)
12/2019 - 02/2005
2Schizophrenia (Dementia Praecox)
01/2018 - 12/2016
2Mania (Manias)
01/2017 - 01/2017
2Human Influenza (Influenza)
12/2011 - 03/2011
1Facial Injuries (Facial Injury)
12/2019
1Eczema
01/2017
1Postpartum Depression (Post-Natal Depression)
01/2017
1Inflammation (Inflammations)
01/2017
1Asthma (Bronchial Asthma)
01/2017
1Major Depressive Disorder (Major Depressive Disorders)
09/2016
1Coinfection
01/2016
1Hepatitis B
01/2016
1Sexually Transmitted Diseases (Sexually Transmitted Disease)
01/2016
1Hemolysis
10/2015
1Pruritus (Itching)
08/2013
1Rupture
08/2013
1Angiomyolipoma
08/2013
1Hemorrhage
08/2013
1Aneurysm (Aneurysms)
08/2013
1Lymphangioleiomyomatosis (Lymphangiomyomatosis)
08/2013
1Tuberous Sclerosis (Bourneville's Disease)
08/2013
1Cystic Fibrosis (Mucoviscidosis)
05/2013
1Methemoglobinemia
11/2012
1Chronic Obstructive Pulmonary Disease (COPD)
03/2011
1Rabies (Hydrophobia)
11/2010
1Psychotic Disorders (Schizoaffective Disorder)
04/2009
1Disease Progression
04/2009
1Breast Neoplasms (Breast Cancer)
02/2009
1Neoplasms (Cancer)
02/2009
1Transitional Cell Carcinoma
12/2008
1Tooth Demineralization
12/2008
1Brain Injuries (Brain Injury)
08/2008
1Stroke (Strokes)
08/2008
1Streptococcal Infections (Streptococcal Infection)
08/2008
1Orthomyxoviridae Infections
04/2007
1Bone Resorption
04/2006
1Convalescence
09/2005
1Mood Disorders (Mood Disorder)
05/2005
1Respiratory Tract Diseases (Respiratory Tract Disease)
08/2003
1Crohn Disease (Crohn's Disease)
11/2002
1Ulcerative Colitis
11/2002
1Pain (Aches)
11/2001

Drug/Important Bio-Agent (IBA)

6Peptides (Polypeptides)IBA
02/2007 - 05/2000
5VaccinesIBA
01/2008 - 08/2001
4ChloratesIBA
11/2012 - 09/2005
4GlucosyltransferasesIBA
02/2007 - 05/2000
3Proteins (Proteins, Gene)FDA Link
12/2011 - 01/2002
3Immunoglobulin A (IgA)IBA
08/2008 - 08/2001
3SodiumIBA
08/2007 - 09/2005
3ractopamineIBA
03/2003 - 05/2002
2C-Reactive ProteinIBA
01/2017 - 03/2011
2Influenza Vaccines (Influenza Vaccine)FDA Link
12/2011 - 04/2007
2EnzymesIBA
08/2008 - 05/2000
2AntigensIBA
01/2008 - 04/2006
2glucan-binding proteinsIBA
02/2005 - 05/2001
2beta Adrenergic ReceptorsIBA
03/2003 - 01/2003
2LigandsIBA
03/2003 - 01/2003
1Genetic Markers (Genetic Marker)IBA
01/2018
1Interleukin-6 (Interleukin 6)IBA
01/2017
1SmokeIBA
01/2017
1Clozapine (Clozaril)FDA LinkGeneric
12/2016
1Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)IBA
09/2016
1Desvenlafaxine SuccinateFDA Link
09/2016
1Serotonin (5 Hydroxytryptamine)IBA
09/2016
1Viral RNAIBA
01/2016
1PotassiumIBA
10/2015
1lipoarabinomannan (LAM)IBA
08/2013
1IronIBA
05/2013
1Hemagglutinins (Hemagglutinin)IBA
12/2011
1AntibodiesIBA
03/2011
1Serum Amyloid A Protein (Serum Amyloid A)IBA
03/2011
1Receptor for Advanced Glycation End ProductsIBA
03/2011
1Immunoglobulins (Immunoglobulin)IBA
11/2010
1Antidepressive Agents (Antidepressants)IBA
04/2009
1Biomarkers (Surrogate Marker)IBA
04/2009
1Tyrosine Kinase InhibitorsIBA
02/2009
1human ERBB2 proteinIBA
02/2009
1Trastuzumab (Herceptin)FDA Link
02/2009
1Lapatinib (GW572016)FDA Link
02/2009
1AcidsIBA
12/2008
1Arsenic Trioxide (Trisenox)FDA Link
12/2008
1AminesIBA
08/2008
1ImmunosorbentsIBA
08/2008
1Amine Oxidase (Copper-Containing)IBA
08/2008
1Drinking WaterIBA
11/2006
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
05/2005
1poly(lactide) (polylactic acid)IBA
02/2005
1Glutathione (Reduced Glutathione)IBA
02/2005
1salicylhydroxamic acid (SHAM)IBA
08/2003
1Adrenal Cortex Hormones (Corticosteroids)IBA
11/2002
1Adrenergic Agents (Adrenergic Drugs)IBA
05/2002
1Conjugate VaccinesIBA
01/2002

Therapy/Procedure

1Vascularized Composite Allotransplantation
12/2019
1Cesarean Section (Caesarean Section)
08/2013
1Therapeutics
02/2009
1Nephrectomy
09/2005